Clinical Trial Update: Axatilimab in Combination With Extracorporeal Photopheresis (ECP) in Chronic Graft-versus-Host Disease [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating Axatilimab in combination with extracorporeal photopheresis for chronic graft-versus-host disease (cGVHD) is currently recru…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Graft-versus-host Disease

Drugs mentioned

• Axatilimab (axatilimab)

Snippet

Sponsor: University of Miami | Conditions: Chronic Graft Versus Host Disease, cGVHD | Phase 2 | Status: RECRUITING